Embed Size (px)
Citation preview
Course DirectorsAna-Maria Forsea, Bucharest, Romania
Claus Garbe, Tuebingen, GermanyAxel Hauschild, Kiel, Germany
Judit Oláh, Szeged, Hungary
8th EUROPEAN SCHOOL OF DERMATO-ONCOLOGY UPDATE ON CUTANEOUS ONCOLOGY (ESDO)JANUARY 16th–18th, 2020ABBA HOTEL BERLIN, GERMANY
www.dermato-oncology2020.org
update 28/10/2019
European Association of Dermato-Oncology (EADO) 2
Target Audience 2
Educational Objectives 2
Course Organization 3
Program Overview 4
Program 6
Thursday, January 16th, 2020 6
Friday, January 17th, 2020 7 Non-Melanoma Skin Cancer Day
Saturday, January 18th, 2020 10
Course Faculty 11
General Information 15
Registration Form 17
www.dermato-oncology2020.org
Content
2
European Association of Dermato-Oncology (EADO)
The EADO is a non-profit organization funded in 1999 to promote, coordinate and improve clinical and laboratory research activities in the field of skin cancer including primary and sec-ondary prevention, early detection, clinical diagnosis and clinical and experimental research. EADO has organized many successful meetings and the upcoming ones are visible on the website (www.eado.org).The EADO initiates for the eighth time a course dedicated to fundamentals in skin cancer targeted to specialists and residents in the final phase of their resident program. They will benefit a comprehensive and updated course to improve their decision-making process for the management of all types and stages of skin cancer, from diagnosis, primary treatment and adjuvant treatment, to the management of locoregional disease and distant metastatic disease.
Target Audience
This 2,5-day educational course targets doctors who are actively involved in the treatment of skin cancer. Dermatologists or other specialists who have completed specialist training, or residents in the final year of their training program, are likely to gain the most from this course.
Educational Objectives
The principal aim of the course is to provide a comprehensive and detailed understanding of the decision-making process for the management of all types and stages of skin cancer. This will include diagnosis and primary treatment, management of locoregional disease and distant metastatic disease, and adjuvant treatment. This is particularly relevant given the rapid progress in our understanding of melanoma and non-melanoma skin cancer, and the development of new treatments. In particular delegates will acquire the following knowledge:
1. Strategies for diagnosis of melanoma, Merkel cell and non-melanoma skin cancer including dermoscopy and confocal laser microscopy.
2. The indications, risks and benefits and strategies for mole screening.
3. Diagnosis of skin cancer: how to break bad news.
3
4. The indications and methods for genetic diagnosis and genetic counseling of skin cancer patients.
5. The present AJCC staging systems and how to stage melanoma, Merkel cell and cutaneous squamous cell carcinoma, and other non-melanoma skin cancers.
6. The value of imaging and biomarkers for the detection of metastases and disease staging.
7. Adjuvant treatment of skin cancer: radiotherapy, immunotherapy, chemotherapy.
8. New systemic treatments for stage IV melanoma: targeted agents and immuno-therapeutics.
9. New treatment options of advanced basal cell carcinoma.
10. New systemic treatments for advanced Merkel cell and squamous cell carcinoma.
11. The characteristics of mucosal and uveal melanomas and their treatment options.
12. Options for topical treatment of epithelial skin cancers.
13. The current classification of cutaneous lymphoma, staging and treatment options for different subtypes of cutaneous lymphoma.
14. Clinical trials in skin cancer: an update.
15. The indications and strategies for supportive treatments including best supportive care.
Course Organization
The course consists of plenary sessions and interactive outbreak sessions. Plenary sessions will comprise clear structured and up-to-date presentations followed by audience discussion. Voting devices will be used to respond to multiple choice questions. These questions may precede the presentation of the structured knowledge or may be presented at the end in order to test the level of knowledge the audience has gained. The main part of the course consists of 8 interactive sessions, each with no more than 30 at-tendants. Every participant takes part in each of these sessions which mainly comprise case-based discussion. These will be used to illustrate treatment pathways, how risk and benefit are assessed, and how management decisions are made.
We look forward to welcoming you in Berlin in January 2020!
Ana-Maria Forsea, MD Claus Garbe, MD Axel Hauschild, MD Judit Oláh, MD
Course Directors
4
8:00 9:00 10:00 11:00 12:00
Group I
Group II
Group III
Group IV
Thursday January 16th, 2020
Group I
Group II
Group III
Group IV
Bre
ak
Bre
ak
Lunc
h
Friday January 17th, 2020 Non-Melanoma Skin Cancer Day
COURSE E A. M. Forsea
COURSE F M. WEICHENTHAL
COURSE F M. WEICHENTHAL
COURSE G R. Kaufmann
COURSE G R. Kaufmann
COURSE H A. Hauschild
COURSE H A. Hauschild
COURSE E A. M. Forsea
Group I
Group II
Group III
Group IV
Saturday January 18th, 2020
Lectures: Pamplona + Santander Course A+E: Pamplona Course B+F: Santander Course C+G: Burgos Course D+H: Salamanca
All meeting rooms are located on the ground floor.
PLE
NA
RY
SES
SIO
N 2
A
.Str
atig
os
D. S
chad
endo
rf
V. d
el M
arm
ol
C. G
arbe
PLE
NA
RY
SES
SIO
N 4
L.
K. S
ecul
ovic
J.
Olá
h
R. V
ieira
Ch
. Geb
hard
t
Bre
ak
Bre
ak
Program OverviewA commercial exhibition will be held on
all days close to the meeting rooms.
COURSE C C. GARBE
COURSE D P. NATHAN
COURSE A J. J. Grob
COURSE B C. Lebbé
COURSE D P. NATHAN
COURSE A J. J. Grob
COURSE B C. Lebbé
COURSE C C. GARBE
5
13:00 14:00 15:00 16:00 17:00 18:00
Wel
com
e Se
ssio
n
PLE
NA
RY
SES
SIO
N 1
I.
Zala
udek
A
. Lal
las
J. M
alve
hy
C. H
ölle
r
Bre
ak
Bre
ak
COURSE A J. J. Grob
COURSE B C. Lebbé
COURSE B C. Lebbé
COURSE C C. GARBE
COURSE C C. GARBE
COURSE D P. NATHAN
COURSE D P. NATHAN
COURSE A J. J. Grob
Non-Melanoma Skin Cancer Day
Bre
ak
Bre
ak
CUTA
NEO
US
SID
E EF
FECT
S
TR
EATM
ENT
O
PTI
ON
S
COURSE G R. Kaufmann
COURSE H A. Hauschild
COURSE H A. Hauschild
COURSE E A. M. Forsea
COURSE E A. M. Forsea
COURSE F M. WEICHENTHAL
COURSE G R. KaufmannP
LEN
AR
Y S
ESSI
ON
3
H. H
änßl
e K
. Per
is
A. M
. For
sea
P. A
renb
erge
r D
. Mor
eno
COURSE F M. WEICHENTHAL
6
Thursday, January 16th, 2020
13:45 –14:00 Welcome and course introduction Claus Garbe, Tuebingen, Germany
PLENARY SESSION 1: What is new in diagnostics and treatment? Chairpersons: Iris Zalaudek and Joseph Malvehy
14:00 –14:15 LECTURE 1: Dermoscopy of difficult lesions – beyond ABCD Pamplona+Santander Iris Zalaudek, Trieste, Italy
14:20 –14:35 LECTURE 2: Computer dermoscopy: a must? Pamplona+Santander Aimilios Lallas, Thessaloniki, Greece
14:40 –14:55 LECTURE 3: Update on imaging tools in skin cancers Pamplona+Santander Josep Malvehy, Barcelona, Spain
15:00 –15:15 LECTURE 4: The neoadjuvant approach in skin cancer Pamplona+Santander Christoph Höller, Vienna, Austria
15:15 –15:30 Discussion
15:30 –16:00 Coffee Break
16:00 –17:00 COURSE A: Clinical trials fundamentals- understanding trial Group I Pamplona design, data analysis, result interpretation and ethical issues
Jean Jacques Grob, Marseille, France
16:00 –17:00 COURSE B: How to organize a skin cancer center? Group II Santander Celeste Lebbé, Paris, France
16:00 –17:00 COURSE C: Management of melanoma patients stages I–III Group III Burgos Claus Garbe, Tuebingen, Germany
16:00 –17:00 COURSE D: Targeted therapy of melanoma, SCC, BCC and DFSP Group IV Salamanca Paul Nathan, Northwood, United Kingdom
Program
7
17:00 –17:30 Coffee Break
17:30 –18:30 COURSE B: How to organize a skin cancer center? Group I Pamplona Celeste Lebbé, Paris, France
17:30 –18:30 COURSE C: Management of melanoma patients stages I–III Group II Santander Claus Garbe, Tuebingen, Germany
17:30 –18:30 COURSE D: Targeted therapy of melanoma, SCC, BCC and DFSP Group III Burgos Paul Nathan, Northwood, United Kingdom
17:30 –18:30 COURSE A: Clinical trials fundamentals- understanding trial Group IV Salamanca design, data analysis, result interpretation and ethical issues Jean Jacques Grob, Marseille, France
Friday, January 17th, 2020 Non-Melanoma Skin Cancer Day
PLENARY SESSION 2: Controversies in Dermatooncology Chairpersons: Jean Jacques Grob and Alex Stratigos
08:00 –08:15 LECTURE 5: Skin cancer screening saves lifes: Yes Pamplona+Santander Alex Stratigos, Athens, Greece
08:15 –08:30 LECTURE 6: Skin cancer screening saves lifes: No Pamplona+Santander Dirk Schadendorf, Essen, Germany
08:30 –08:45 Discussion
08:45 –09:00 LECTURE 7: Sunscreens prevent skin cancer: Yes Pamplona+Santander Veronique del Marmol, Brussels, Belgium
09:00 –09:15 LECTURE 8: Sunscreens prevent skin cancer: No Pamplona+Santander Claus Garbe, Tuebingen, Germany
09:15 –09:30 Discussion
09:30 –10:00 Coffee Break
8
10:00 –11:00 COURSE E: Principals of follow-up in skin cancer patients Group I Pamplona Ana Maria Forsea, Bucharest, Romania
10:00 –11:00 COURSE F: Cutaneous lymphomas: diagnosis and management Group II Santander Michael Weichenthal, Kiel, Germany
10:00 –11:00 COURSE G: Surgical pearls in the treatment Group III Burgos of keratinocyte skin cancer Roland Kaufmann, Frankfurt, Germany
10:00 –11:00 COURSE H: Immune checkpoint inhibition for melanoma, Group IV Salamanca MCC, SCC and BCC Axel Hauschild, Kiel, Germany
11:00 –11:30 Coffee Break
11:30 –12:30 COURSE F: Cutaneous lymphomas: diagnosis and management Group I Pamplona Michael Weichenthal, Kiel, Germany
11:30 –12:30 COURSE G: Surgical pearls in the treatment Group II Santander of keratinocyte skin cancer
Roland Kaufmann, Frankfurt, Germany
11:30 –12:30 COURSE H: Immune checkpoint inhibition for melanoma, Group III Burgos MCC, SCC and BCC Axel Hauschild, Kiel, Germany
11:30 –12:30 COURSE E: Principals of follow-up in skin cancer patients Group IV Salamanca Ana Maria Forsea, Bucharest, Romania
12:30 –13:00 Lunch
PLENARY SESSION 3: New challenges in skin cancer treatment Chairpersons: Holger Hänßle and Ketty Peris
13:00 –13:30 LECTURE 9: Artificial intelligence in skin cancer diagnosis Pamplona+Santander Holger Hänßle, Heidelberg, Germany
13:30-14:00 LECTURE 10: What is new for actinic keratosis? Pamplona+Santander Ketty Peris, Rome, Italy
14:00 –15:00 Non-Melanoma skin cancer cases – interactive presentation to Pamplona+Santander the tumor board Ana Maria Forsea, Petr Arenberger, David Moreno
9
15:00 –15:30 Coffee Break
15:30 –16:30 COURSE G: Surgical pearls in the treatment Group I Pamplona of keratinocyte skin cancer
Roland Kaufmann, Frankfurt, Germany
15:30 –16:30 COURSE H: Immune checkpoint inhibition for melanoma, Group II Santander MCC, SCC and BCC
Axel Hauschild, Kiel, Germany
15:30 –16:30 COURSE E: Principals of follow-up in skin cancer patients Group III Burgos Ana Maria Forsea, Bucharest, Romania
15:30 –16:30 COURSE F: Cutaneous lymphomas: diagnosis and management Michael Weichenthal, Kiel, Germany
16:30 –17:00 Coffee Break
17:00 –18:00 COURSE H: Immune checkpoint inhibition for melanoma, Group I Pamplona MCC, SCC and BCC
Axel Hauschild, Kiel, Germany
17:00 –18:00 COURSE E: Principals of follow-up in skin cancer patients Group II Santander Ana Maria Forsea, Bucharest, Romania
17:00 –18:00 COURSE F: Cutaneous lymphomas: diagnosis and management Group III Burgos Michael Weichenthal, Kiel, Germany
17:00 –18:00 COURSE G: Surgical pearls in the treatment Group IV Salamanca of keratinocyte skin cancer Roland Kaufmann, Frankfurt, Germany
10
Saturday, January 18th, 2020
08:30 –09:30 COURSE C: Management of melanoma patients stages I–III Group I Pamplona Claus Garbe, Tuebingen, Germany
08:30 –09:30 COURSE D: Targeted therapy of melanoma, SCC, BCC and DFSP Group II Santander Paul Nathan, Northwood, United Kingdom
08:30 –09:30 COURSE A: Clinical trials fundamentals- understanding trial Group III Burgos design, data analysis, result interpretation and ethical issues Jean Jacques Grob, Marseille, France
08:30 –09:30 COURSE B: How to organize a skin cancer center? Group IV Salamanca Celeste Lebbé, Paris, France
09:30 –10:00 Coffee Break
10:00 –11:00 COURSE D: Targeted therapy of melanoma, SCC, BCC and DFSP Group I Pamplona Paul Nathan, Northwood, United Kingdom
10:00 –11:00 COURSE A: Clinical trials fundamentals- understanding trial Group II Santander design, data analysis, result interpretation and ethical issues
Jean Jacques Grob, Marseille, France
10:00 –11:00 COURSE B: How to organize a skin cancer center? Group III Burgos Celeste Lebbé, Paris, France
10:00 –11:00 COURSE C: Management of melanoma patients stages I–III Group IV Salamanca Claus Garbe, Tuebingen, Germany
11:00 –11:30 Coffee Break
PLENARY SESSION 4: Melanoma diagnostics and follow-up Chairpersons: Ketty Peris
11:30 –12:00 LECTURE 11: Targeted therapies: management of adverse events Pamplona+Santander Lidija Kandolf Sekulovic, Belgrade, Serbia
12:00 –12:30 LECTURE 12: Immune checkpoint inhibition: Pamplona+Santander management of adverse events Christoffer Gebhardt, Hamburg, Germany
12:30 –13:30 Melanoma cases – interactive presentation to the tumor board Pamplona+Santander Judit Oláh, Lidija Kandolf, Ricardo Vieira
11
A
Petr Arenberger, MDProfessor of Dermatology, Director Department of DermatologyCharles University3rd School of MedicineSrobarova 50CZ-100 34 Prague, Czech RepublicPhone: +420-26716-3000Email: [email protected]
D
Veronique Del Marmol, MDDepartment of Clinical ChemistryErasme Hospital – ULBRoute de Lennik 8081070 Brussels, Belgium
F
Ana-Maria Forsea, MDAssistant Professor for DermatologyDepartment of DermatologyCarol Davila University of Medicineand Pharmacy BucharestBulevardul Eroii Sanitari 8050474 Bucharest, RomaniaPhone: +40-21-3180462Email: [email protected]
G
Claus Garbe, MDProfessor of DermatologyDepartment of DermatologyEberhard Karls University Liebermeister Str. 2572076 Tuebingen, GermanyPhone: +49-7071-2987110Email: [email protected]
Christoffer Gebhardt, MDSkin Cancer CenterUniversity Hospital Hamburg-EppendorfMartinistr. 5220246 Hamburg, GermanyPhone: +49-40-741057626Email: [email protected]
Jean Jacques Grob, MDProfessor of DermatologyService de Dermatology and Cancer ResearchHôpital de la Timone 264 Rue St. Pierre 13005 Marseille, FrancePhone: +33-491-388591Email: [email protected]
Invited Course Faculty
12
H
Holger Hänßle, MDHeidelberg University HospitalIm Neuenheimer Feld 40069120 Heidelberg, Germany
Axel Hauschild, MDProfessor of Dermatology Department of Dermatology University of Kiel Rosalind-Franklin-Str. 724105 Kiel, GermanyPhone: +49-431-50021131Email: [email protected]
Christoph Höller, MDProfessor of DermatologyDepartment of Dermatology Medical University of Vienna Waehringer Guertel 18–201090 Vienna, AustriaPhone: +43-1-404004786Email: christoph.hoeller@meduniwien. ac.at
K
Lidija Kandolf Sekulovic, MDProfessor of DermatologyDepartment of DermatologyMedical FacultyMilitary Medical AcademyCrnotravska 1711000 Belgrade, SerbiaPhone: +381-11-3608583Email: [email protected]
Roland Kaufmann, MDProfessor of Dermatology, Director Department of DermatologyClinical Center J. W. Goethe University Theodor-Stern-Kai 760590 Frankfurt/Main, GermanyPhone: +49-69-63015311Email: [email protected]
L
Aimilios Lallas, MDAristotle University of ThessaloikiDepartment of Dermatology54124 Thessaloniki, Greece
Celeste Lebbé, MDProfessor of DermatologyDepartment of DermatologyHôpital Saint-Louis1, Avenue Claude-Vellefaux75010 Paris, FrancePhone: +33-142494679Email: [email protected]
M
Josep Malvehy, MDDirector of the Melanoma Unit Department of Dermatology Hospital Clinic of Barcelona C/Villarroel 17008036 Barcelona, SpainPhone: +34-933638920Email: [email protected]
13
David Moreno-Ramirez, MDUniversity Hospital Virgen MacarenaCalle Dr. Fedriani, 341009 Seville, Spain
N
Paul Nathan, MDMount Vernon Cancer CentreRickmansworth Rd, NorthwoodUnited KingdomEmail: [email protected]
O
Judit Oláh, MD Department of DermatologyUniversity of SzegedKoranyi Fasor 63720 Szeged, HungaryPhone: +36-62-545984Email: [email protected]
P
Ketty Peris, MDDepartment of DermatologyCatholic University of RomeLargo a Gemelli, 800168 Rome, ItalyPhone: +39-630154227Email: [email protected]
S
Dirk Schadendorf, MDUniversity Hospital of EssenHufelandstr. 5545147 Essen, GermanyPhone: +49-201-7232430Email: [email protected]
Alexander Stratigos, MDDepartment of DermatologyUniversity of Athens School of Medicine Andreas Sygros Hospital5 Dragoumi StreetAthens 161 21, GreecePhone: +30-210-7231731Email: [email protected]
V
Ricardo Vieira, MDFaculty of MedicineUniversity of CoimbraPólo I – Edífico CentralRua Larga3004-504 Coimbra, PortugalPhone: +35-1-3957-00Email: [email protected]
14
W
Michael Weichenthal, MDProfessor of DermatologyDepartment of DermatologyUniversity of KielRosalind-Franklin-Str. 724105 Kiel, GermanyPhone: +49-431-500-21141Email:[email protected]
Z
Iris Zalaudek, MDHead of the Dermatology ClinicUniversity of TriesteHospital MaggiorePiazza dell' Ospedale 134125 Trieste, ItalyEmail: [email protected]
15
Cancellation PolicyCancellations must be received in writing by December 19, 2019. No refunds will be granted after that date. A processing fee of 30 Euro will be deducted from each can-celled registration. Substitutions are possible. To substitute a registration, please send an email including the name of the original registrant and the name of the person substituting to [email protected].
The participant acknowledges that he/she has no right to lodge damage claims against the organizers should the holding of the meeting be hindered or prevented by unex-pected, political or economic events or generally by force, or should the non-appearance of speakers or other reasons need program changes. With registration, the participant accepts this proviso.
Course Organization
MedConcept Gesellschaft für medizinische Projekte mbH Friedenstraße 58 15366 Neuenhagen b. Berlin, Germany Phone: +49 (0)3342 42689-30 Fax: +49 (0)3342 42689-40 E-Mail: [email protected] www.medconcept.org
Course VenueABBA Hotel BerlinLietzenburger Str. 8910719 BerlinGermany
Phone: +49 (0)30 8871860 E-Mail: [email protected]
General Information
16
Exhibition Opening HoursThursday, January 16: 13:00–18:30Friday, January 17: 07:30–18:00Saturday, January 18: 08:00–13:30
FeesRegistration Fee of 380 Euro (incl. VAT) covers
– Admission to scientific sessions – Welcome reception– Admission to exhibition – Coffee breaks and lunch – Bag with course documents – Certificate of attendance
Language and TranslationThe official language of the meeting will be English. Simultaneous translation will not be provided.
Registration / Information DeskThe registration desk is situated at the ground floor of the Novotel Berlin am Tiergarten.
Opening hoursThursday, January 16: 12:00 –19:00 Friday, January 17: 07:30 –18:00 Saturday, January 18: 08:00 –14:00
17
First Name: Last Name:
Professional Title: Degree: MD PhD RN PA-C
Gender: Male Female Speciality:
Institution: Address:
City: Zip Code: Country:
Phone: Fax: E-Mail:
Fees – Registration Fee of 380,00 Euro (incl. VAT) covers
– Admission to scientific sessions – Admission to exhibition – Welcome reception– Bag with course documents – Coffee breaks and lunch – Certificate of Attendance
Payment Method
Bank Transfer: Registration can only be confirmed upon receipt of full payment.
Credit Card: MasterCard Visa American Express
Credit Card Number:
Expiration Date:
Security Code CCV: (MC/Visa – 3 digits on back, AMEX – 4 digits on front)
Cardholder Name:
Signature:
An invoice will be send by email to the given address. If the invoice address is different from the address given above, please send an email including the name of the registrant and the full invoice address to [email protected].
By completing the registration form, the participant accepts the general terms and conditions as well as the cancellation policy given on the congress website at www.melanomaglobal2020.org and agrees that his/her data may be used, processed and published (e.g. within the list of participants) for organizational purposes of the event. The participant accepts that MedConcept will contact him/her by email for organizational matters (e.g. the registration confirmation and invoice) and information related to the event.
I accept until further notice that MedConcept will inform me about future events by email.
To Register
Mail registration form to: MedConcept GmbH, Friedenstraße 58, 15366 Neuenhagen bei Berlin, GermanyFax registration form to: +49 (0)3342 42689-40, Register online: www.dermato-oncology2020.org
Registration Form8th European School of Dermato-Oncology
January 16th–18th, 2020 ABBA Hotel Berlin
Lietzenburger Str. 8910719 Berlin, Germany
18
The EUROPEAN CERTIFICATION for MEDICAL TUMOR THERAPY in DERMATO-ONCOLOGY:Register now for the 2020 Examination!
The professional competence in conducting systemic therapy for skin cancers is certified by the European Certificate for Medical Tumour Therapy in Dermato-oncology awarded by EADO in collaboration with UEMS.
The Certification is acquired upon successfully passing the EADO Exami-nation, which will be held on Saturday 18th January 2020 during the 8th European School of Dermato-Oncology, Berlin, Germany.
The Examination is open for Dermatology specialists and final year residents with clinical experience in the systemic treatment of skin cancers.
Deadline for application: December 1st 2019
Please visit the www.eado.org website to keep informed about the latest updates and feel free to contact the EADO office at [email protected] for any query.
EADO - European Association of Dermato-Oncology.An organization dedicated to promote, coordinate and improve clinical and laboratory research in skin cancer.A non-profit Organization registered in Switzerland,AG Flugofstrasse 54, CH-8152 Glattburg.
Please feel free to contact the Secretariat Office.Tel.: +33 (0)1 53 85 82 70, [email protected], www.eado.org
